For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

We use cookies to make our site as useful as possible.

Our Cookie Policy explains how you can opt-out of the cookies we use.

If you continue without changing your cookie settings, we'll assume you’re happy with this.

Continue Continue

United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Diagnostic & Therapeutic Solutions
    Custom solutions & partnerships

    Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.

    Create custom solutions with us

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Supporting our customers and employees during the COVID-19 pandemic. Read more

The rise of miRNA research

Related

  • Learn about our miRNA assays
    • Benefits of our assays
      • What do I need?
        • Panels for your research
          • Learn more about miRNAs
            • Focus on biomarkers
              • Rise of miRNA research
                • miRNAs in exosomes
                  • Review of methods
                    • Database and target prediction tools index

                    In recent years, much attention has been focused on the regulatory activity of a class of RNAs known as microRNAs (miRNAs).

                    Although there is now widespread interest in miRNAs, this wasn't always the case. Indeed, these short (~22 bp) non-coding RNA sequences were only discovered in 1993 by Victor Ambros and colleagues.

                    The first miRNA precursor discovered, lin-4, was found to regulate worm (Caenorhabditis elegans) development (Lee et al., 1993). Considered an interesting but worm-specific anomaly, the importance of lin-4’s discovery was not fully appreciated at the time.

                    It took several years before researchers noticed that miRNAs, and the genes that process them, were highly conserved across species and worthy of more attention. Once the widespread nature of miRNAs was realized, concerted efforts to discover more miRNAs and elucidate their function began.

                    ​miRBase – a dedicated miRNA annotation database – counts 28,645 entries in more than 100 species to date. Furthermore, recent research suggests that there are many more miRNAs waiting to be discovered (Friedländer et al., 2014).

                    Figure 1. The number of miRNAs in the miRBase database from 2003 to 2014.


                    Decades later, we know that humans express >1,900 miRNAs (www.miRBase.org, 2015), that they regulate the translation of mRNA and can silence genes at the DNA level. Unsurprisingly, such fundamental influence on cell activity has implicated miRNAs in a number of diseases including cancer, neurological disorders and cardiac function (Sayed et al., 2011).

                    miRNAs as biomarkers

                    Anomalous expression of miRNAs has been shown to be a hallmark of specific cancers and, as these molecules have been shown to circulate in the blood, miRNAs look set to become powerful prognostic and diagnostic biomarkers in the years ahead (Schwarzenbach et al., 2014).

                    A recent Cancer Cell paper has illustrated what may be a significant broadening of the miRNA field. A multicenter research effort discovered that breast cancer cells shed more exosomes than healthy cells, and that these exosomes are loaded with miRNAs, primed and ready to regulate their target genes (Melo et al., 2014).

                    This might be just an interesting quirk, after all exosomes are just small membrane bubbles regularly shed by cells; however, the paper’s authors demonstrate that exosomes purified from the sera of cancer patients can instigate tumor formation in healthy epithelial cells.

                    While one paper doesn’t make a field, a similar exosome-mediated shedding of miRNAs and associated processing machinery has been observed in HIV infected cells (Narayanan et al., 2013) and in cells undergoing anoxic stress (Shen et al., 2013). This is just one of a number of reports highlighting opportunities for the development of miRNA-based biomarkers and therapies for cancer and a number of other human diseases (Sundarbose et al., 2013; Van Roosbroeck et al., 2013); this is certainly a field to keep a close eye on.

                    A new multiplex technology to profile miRNAs.

                    Given the emerging role of miRNAs as biomarkers, miRNA profiling has tremendous potential for the diagnosis and prognosis of a broad range of diseases. Using innovative technology, we have developed an assay that enables researchers to detect up to 68 miRNAs of choice either from purified RNA or directly from crude samples including serum, plasma and exosomes.
                     
                    We have demonstrated how the Multiplex Circulating miRNA Assay can be used for miRNA profiling with PCR sensitivity directly from as little as 10 µL of serum or plasma with no need for RNA purification, or from less than 100 pg of purified RNA. The assay allows the parallel processing of 96 samples, thus enabling the high-throughput analysis required for biomarker validation studies.

                    Profile miRNAs direct from biofluids


                    References

                    • Friedländer MR et al. (2014). Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol 15, R57.
                    • Lee RC et al. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854.
                    • Melo SA et al. (2014). Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26, 707–721.
                    • Narayanan A et al. (2013). Exosomes derived from HIV-1 infected cells contain trans-activation response element RNA. J Biol Chem 288, 20014–20033.
                    • Sayed D, Abdellatif M (2011). MicroRNAs in development and disease. Physiol Rev 91, 827–887.
                    • Schwarzenbach H et al. (2014). Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11, 145–146.
                    • Shen J et al. (2013). EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383–387.
                    • Sundarbose K et al. (2013). MicroRNAs as biomarkers in cancer. Diagnostics 3, 84–104.
                    • Van Roosbroeck K et al. (2013). miRNAs and long noncoding RNAs as biomarkers in human disease. Expert Rev Mol Diagn 13, 183–204.
                    • www.mirbase.org/index.shtml (accessed June 19, 2015)
                      ​


                    Firefly® is a registered trade mark in the Unites States and is registered as a European Union Trade Mark.

                    Get resources and offers direct to your inbox Sign up
                    A-Z by research area
                    • Cancer
                    • Cardiovascular
                    • Cell biology
                    • Developmental biology
                    • Epigenetics & Nuclear signaling
                    • Immunology
                    • Metabolism
                    • Microbiology
                    • Neuroscience
                    • Signal transduction
                    • Stem cells
                    A-Z by product type
                    • Primary antibodies
                    • Secondary antibodies
                    • Biochemicals
                    • Isotype controls
                    • Flow cytometry multi-color selector
                    • Kits
                    • Loading controls
                    • Lysates
                    • Peptides
                    • Proteins
                    • Slides
                    • Tags and cell markers
                    • Tools & Reagents
                    Help & support
                    • Support
                    • Make an Inquiry
                    • Protocols & troubleshooting
                    • Placing an order
                    • RabMAb products
                    • Biochemical product FAQs
                    • Training
                    • Browse by Target
                    Company
                    • Corporate site
                    • Investor relations
                    • Company news
                    • Careers
                    • About us
                    • Blog
                    Events
                    • Tradeshows
                    • Conferences
                    International websites
                    • abcam.cn
                    • abcam.co.jp

                    Join with us

                    • LinkedIn
                    • facebook
                    • Twitter
                    • YouTube
                    • Terms of sale
                    • Website terms of use
                    • Cookie policy
                    • Privacy policy
                    • Legal
                    • Modern slavery statement
                    © 1998-2021 Abcam plc. All rights reserved.